1. Home
  2. MOFG vs URGN Comparison

MOFG vs URGN Comparison

Compare MOFG & URGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MidWestOne Financial Gp

MOFG

MidWestOne Financial Gp

HOLD

Current Price

$49.17

Market Cap

861.6M

Sector

Finance

ML Signal

HOLD

Logo UroGen Pharma Ltd.

URGN

UroGen Pharma Ltd.

HOLD

Current Price

$20.54

Market Cap

922.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MOFG
URGN
Founded
1934
2004
Country
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
861.6M
922.1M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
MOFG
URGN
Price
$49.17
$20.54
Analyst Decision
Buy
Strong Buy
Analyst Count
2
8
Target Price
$40.50
$29.50
AVG Volume (30 Days)
204.8K
665.2K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
1.97%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$242.68
$26.47
Revenue Next Year
$7.66
$110.65
P/E Ratio
$17.52
N/A
Revenue Growth
N/A
N/A
52 Week Low
$24.62
$3.42
52 Week High
$49.69
$30.00

Technical Indicators

Market Signals
Indicator
MOFG
URGN
Relative Strength Index (RSI) 75.63 47.30
Support Level $47.16 $19.65
Resistance Level $49.26 $21.62
Average True Range (ATR) 1.22 1.33
MACD 0.05 0.07
Stochastic Oscillator 92.35 45.26

Price Performance

Historical Comparison
MOFG
URGN

About MOFG MidWestOne Financial Gp

MidWestOne Financial Group Inc is a bank holding company engaged in delivering relationship-based business and personal banking products and services. The Bank provides commercial loans, real estate loans, agricultural loans, credit card loans, and consumer loans. It also provides deposit products including demand and interest checking accounts, savings accounts, money market accounts, and time deposits. The Bank also provides products and services including treasury management, Zelle, online and mobile banking, debit cards, ATMs, and safe deposit boxes. The Bank offers its products and services through its network of full-service banking offices. the Bank's investments services department offers financial planning, investment advisory, and retail securities brokerage services.

About URGN UroGen Pharma Ltd.

UroGen Pharma Ltd is a clinical-stage biotechnology firm specializing in solutions for urothelial and specialty cancers. The company has developed RTGel reverse-thermal hydrogel, a proprietary technology enhancing the therapeutic profiles of existing drugs by enabling sustained release. Their flagship product, Jelmyto (mitomycin) for pyelocalyceal solution, along with investigational candidate UGN-102 (mitomycin) for intravesical solution, targets non-surgical tumor ablation in forms of non-muscle invasive urothelial cancer. Additionally, their immuno-uro-oncology pipeline includes UGN-301 (zalifrelimab), an anti-CTLA-4 antibody, intended for both monotherapy and combination therapy. Revenue is generated from product sales.

Share on Social Networks: